Predicting Severe Dengue Using NLR and PLR: A Cross-Sectional Analytical Study
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.250 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Manzalat Fatima und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Dengue is a major public health concern with a wide clinical spectrum, ranging from mild illness to life-threatening complications. Early identification of severe dengue remains challenging. Hematological indices such as neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have emerged as potential predictors of disease severity.
Methods
This cross-sectional study included 147 laboratory-confirmed dengue patients. Clinical, hematological, and biochemical parameters were recorded at admission. Patients were classified according to World Health Organization. NLR and PLR were calculated from complete blood counts. Statistical analysis included group comparisons, ROC curve analysis, and multivariate logistic regression to identify independent predictors of severity.
Results
Severe dengue was observed in 30.6% of patients. NLR was significantly higher (3.62 ± 1.41 vs 1.94 ± 0.88; p
Zitieren
APA
Fatima, M., Puri, N., & Jawed, M. Q. (2026). Predicting Severe Dengue Using NLR and PLR: A Cross-Sectional Analytical Study. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.250
Vancouver
Fatima M, Puri N, Jawed MQ. Predicting Severe Dengue Using NLR and PLR: A Cross-Sectional Analytical Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.250
BibTeX
@article{Fatima2026,
author = {Fatima, Manzalat and Puri, Neeti and Jawed, Md. Quaisar},
title = {Predicting Severe Dengue Using NLR and PLR: A Cross-Sectional Analytical Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.250}
}
EUVIMED